While Alzheimer's disease is the most common type of dementia, there's another variation that is also relatively prevalent. Lewy body dementia (LBD) affects more than 1 million people in the US. It is ...
Cognition Therapeutics, Inc. announced positive results from its Phase 2 trials of zervimesine (CT1812) in treating dementia with Lewy bodies (DLB) and Alzheimer’s disease, indicating significant ...
Lewy body dementia is a progressive neurodegenerative disorder brought on by an excess of the protein alpha-synuclein in the brain. These deposits, known as Lewy bodies, can inhibit the production of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback